Pfizer Shares Hit 10-Year Low on Falling Earnings

Pfizer’s shares haven’t been this low since Oct. 1, 1997, back when the Health Blog was a college freshman. Some Wall Street analysts were pretty glum about the company’s first-quarter earnings announcement. Profit fell 18%, cholesterol drug Lipitor saw another decline despite competing Vytorin’s woes, and sales of allergy drug Zyrtec and blood-pressure remedy [...]